KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Short term Debt: 2017-2024

Historic Short term Debt for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Dec 2024 value amounting to $224.2 million.

  • Amneal Pharmaceuticals' Short term Debt fell 96.79% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year decrease of 96.79%. This contributed to the annual value of $224.2 million for FY2024, which is 25.26% up from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Short term Debt stood at $224.2 million for FY2024, which was up 25.26% from $179.0 million recorded in FY2023.
  • In the past 5 years, Amneal Pharmaceuticals' Short term Debt ranged from a high of $224.2 million in FY2024 and a low of $44.2 million during FY2020.
  • Over the past 3 years, Amneal Pharmaceuticals' median Short term Debt value was $179.0 million (recorded in 2023), while the average stood at $154.4 million.
  • Data for Amneal Pharmaceuticals' Short term Debt shows a peak YoY surged of 198.33% (in 2023) over the last 5 years.
  • Amneal Pharmaceuticals' Short term Debt (Yearly) stood at $44.2 million in 2020, then grew by 8.21% to $47.9 million in 2021, then climbed by 25.36% to $60.0 million in 2022, then spiked by 198.33% to $179.0 million in 2023, then grew by 25.26% to $224.2 million in 2024.